JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB1044

Anti-p13 antibody [BM3]

Be the first to review this product! Submit a review

|

(2 Publications)

Mouse Monoclonal CSL4 antibody. Suitable for ELISA and reacts with Human samples. Cited in 2 publications.

View Alternative Names

CSL4, CGI-108, EXOSC1, Exosome complex component CSL4, Exosome component 1

Key facts

Host species

Mouse

Clonality

Monoclonal

Clone number

BM3

Isotype

IgG1

Light chain type

kappa

Carrier free

No

Reacts with

Human

Applications

ELISA

applications

Specificity

This protein A purified mouse monoclonal antibody reacts specifically with p13 in human granulocytes and monocytes residing in lymphoid and non-lymphoid tissues The antibody recognizes a 13 kDa band corresponding to p13. Cross reactivity from other sources has not been determined.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "ELISA" : {"fullname" : "ELISA", "shortname":"ELISA"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "ELISA-species-checked": "guaranteed", "ELISA-species-dilution-info": "1/5000 - 1/20000", "ELISA-species-notes": "<p></p>" } } }

Product details

BM3 is an early marker of myeloid differentiation. Immunoprecipitation experiments using S35 methionine labeled human myeloid leukemia cells show that BM3 identifies a 13 kDa protein.

The antibody does not stain tissue after paraffin treatment.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Purification notes
This protein A purified mouse monoclonal antibody reacts specifically with p13 in human granulocytes and monocytes residing in lymphoid and non-lymphoid tissues.
Storage buffer
pH: 7.2 Preservative: 0.01% Sodium azide Constituents: 0.88% Sodium chloride, 0.424% Potassium phosphate solution
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

P13 also known as MAPK-interacting serine/threonine-protein kinase 1 (MNK1) is a protein with a mass of approximately 51 kDa. This protein functions as a kinase meaning it adds phosphate groups to other molecules often regulating their activity. p13 is expressed in various tissues but it shows higher expression in the brain and testes. Like many kinases it modulates cellular processes by phosphorylating substrates which leads to changes in their function and consequently impacts cell signaling pathways.
Biological function summary

The kinase activity of p13 influences several processes by participating in the regulation of mRNA translation. It binds to and phosphorylates the eukaryotic translation initiation factor 4E (eIF4E) which is a component of the eIF4F complex responsible for initiating protein synthesis. By phosphorylating eIF4E p13 affects translation rates and potentially influences the production of proteins from specific mRNAs thereby indirectly controlling various cellular functions.

Pathways

P13 plays roles in the mitogen-activated protein kinase (MAPK) signaling and mammalian target of rapamycin (mTOR) pathways. These pathways regulate cell growth proliferation and survival. In the MAPK pathway p13 can interact with various other kinases such as ERK and integrate signals that influence translation. The mTOR pathway involves complex signaling networks where p13 modulates translation machinery components. Through these pathways p13 interconnects with proteins like RPS6KB1 further illustrating its role in controlling protein synthesis and cellular growth.

P13 has been linked to cancer and neurodegenerative diseases. In cancer its elevated activity may lead to increased protein synthesis and cell proliferation contributing to tumorigenesis. For instance its interplay with eIF4E has been observed in several malignancies suggesting a potential therapeutic target in oncology. In neurodegenerative diseases aberrant signaling involving p13 may alter neuron function or survival possibly involving proteins like mTOR which when dysregulated contribute to the pathophysiology of conditions like Alzheimer's disease.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Non-catalytic component of the RNA exosome complex which has 3'->5' exoribonuclease activity and participates in a multitude of cellular RNA processing and degradation events. In the nucleus, the RNA exosome complex is involved in proper maturation of stable RNA species such as rRNA, snRNA and snoRNA, in the elimination of RNA processing by-products and non-coding 'pervasive' transcripts, such as antisense RNA species and promoter-upstream transcripts (PROMPTs), and of mRNAs with processing defects, thereby limiting or excluding their export to the cytoplasm. The RNA exosome may be involved in Ig class switch recombination (CSR) and/or Ig variable region somatic hypermutation (SHM) by targeting AICDA deamination activity to transcribed dsDNA substrates. In the cytoplasm, the RNA exosome complex is involved in general mRNA turnover and specifically degrades inherently unstable mRNAs containing AU-rich elements (AREs) within their 3' untranslated regions, and in RNA surveillance pathways, preventing translation of aberrant mRNAs. It seems to be involved in degradation of histone mRNA. The catalytic inactive RNA exosome core complex of 9 subunits (Exo-9) is proposed to play a pivotal role in the binding and presentation of RNA for ribonucleolysis, and to serve as a scaffold for the association with catalytic subunits and accessory proteins or complexes. EXOSC1 as peripheral part of the Exo-9 complex stabilizes the hexameric ring of RNase PH-domain subunits through contacts with EXOSC6 and EXOSC8.
See full target information EXOSC1

Publications (2)

Recent publications for all applications. Explore the full list and refine your search

Cell metabolism 33:1701-1715.e5 PubMed34118189

2021

Peroxidation of n-3 and n-6 polyunsaturated fatty acids in the acidic tumor environment leads to ferroptosis-mediated anticancer effects.

Applications

Unspecified application

Species

Unspecified reactive species

Emeline Dierge,Elena Debock,Céline Guilbaud,Cyril Corbet,Eric Mignolet,Louise Mignard,Estelle Bastien,Chantal Dessy,Yvan Larondelle,Olivier Feron

The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 63:646-62 PubMed26216140

2015

Characterization of Antibodies to Products of Proinsulin Processing Using Immunofluorescence Staining of Pancreas in Multiple Species.

Applications

Unspecified application

Species

Unspecified reactive species

Ali Asadi,Jennifer E Bruin,Timothy J Kieffer
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com